Rilapladib

A potent, selective and oral lipoprotein-associated phospholipase A2 (Lp-PLA2) inhibitor with IC50 of 0.23 nM.

412950-08-4

≥ 2 years

>98% (HPLC)

735.814

C40H38F5N3O3S

Research use only, not for human use.

Phospholipase

Curated Selection

Explore Other Products

Discover premium biology products from our extensive collection of 20M+ items

MR218274A1V 250 µL

Ask

Oneq-V271-100R 100 Reactions

Ask

LS009976-20ug 20 µg

Ask

SI010355B 1 Each

Ask

MBS1372193-01 0.02 mg (E-Coli)

Ask

MBS1372193-02 0.1 mg (E-Coli)

Ask